- Home
- HWH vs BFRI Comparison
HWH vs BFRI Comparison
Compare HWH & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HWH | BFRI |
|---|---|---|
| Founded | 2021 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 11.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HWH | BFRI |
|---|---|---|
| Price | $1.77 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 18.8K | ★ 195.1K |
| Earning Date | 10-22-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,099,428.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.11 |
| 52 Week Low | $0.90 | $0.54 |
| 52 Week High | $7.77 | $1.87 |
Technical Indicators
Market Signals| Indicator | HWH | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 41.90 |
| Support Level | $1.52 | $0.77 |
| Resistance Level | $1.80 | $0.87 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 68.57 | 57.01 |
Price Performance
Historical ComparisonAbout HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.